Walleye Capital’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-383,591	Closed	-$32M	–	5449
2024 Q4	$32M	Buy	383,591 +134,203	+54%	+$11M	0.31%	197
2024 Q3	$18.2M	Buy	249,388 +13,601	+6%	+$1.02M	0.19%	373
2024 Q2	$16.1M	Buy	235,787 +80,649	+52%	+$5.59M	0.17%	468
2024 Q1	$10.7M	Buy	+155,138	New	+$10.7M	0.12%	789
2023 Q4	–	Sell	-134,655	Closed	-$7.75M	–	6081
2023 Q3	$7.01M	Buy	+134,655	New	+$7.84M	0.1%	801
2023 Q2	–	Sell	-226,402	Closed	-$14.1M	–	5430
2023 Q1	$12.3M	Buy	226,402 +16,690	+8%	+$807K	0.25%	110
2022 Q4	$11.1M	Buy	209,712 +4,149	+2%	+$208K	0.24%	107
2022 Q3	$9.56M	Buy	205,563 +108,153	+111%	+$5.65M	0.22%	119
2022 Q2	$5.56M	Buy	97,410 +27,691	+40%	+$1.57M	0.16%	150
2022 Q1	$4.27M	Buy	69,719 +51,841	+290%	+$2.69M	0.12%	190
2021 Q4	$936K	Sell	17,878 -86,547	-83%	-$3.64M	0.03%	636
2021 Q3	$3.89K	Buy	104,425 +16,772	+19%	+$583K	0.12%	123
2021 Q2	$3.58K	Buy	87,653 +23,599	+37%	+$872K	0.13%	132
2021 Q1	$2.17K	Sell	64,054 -1,346	-2%	-$46.7K	0.14%	131
2020 Q4	$2.08K	Buy	+65,400	New	+$1.72M	0.16%	121
2020 Q1	–	Sell	-41,068	Closed	-$1.41M	–	2038
2019 Q4	$1.41M	Buy	41,068 +22,768	+124%	+$273K	0.31%	301
2019 Q3	$137K	Buy	+18,300	New	+$175K	0.09%	1336
2019 Q2	–	Sell	-7,605	Closed	-$92K	–	2492
2019 Q1	$92K	Buy	+7,605	New	+$97.2K	0.13%	1062